Cargando…
Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
Neoadjuvant chemotherapy (NAC) has been widely used in patients with breast cancer to minish tumor burden and increase resection rate of cancer. T-cell repertoire has been believed to be able to monitor antitumor immune responses. This study aimed to explore the dynamic change of T-cell repertoire a...
Autores principales: | Cai, Gengxi, Guan, Zhanwen, Jin, Yabin, Su, Zuhui, Chen, Xiangping, Liu, Qing, Wang, Chunlin, Yin, Xiaoxia, Zhang, Lifang, Ye, Guolin, Luo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769146/ https://www.ncbi.nlm.nih.gov/pubmed/35025620 http://dx.doi.org/10.1200/PO.21.00120 |
Ejemplares similares
-
The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy
por: Zhang, Yu, et al.
Publicado: (2020) -
The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy
por: Su, Zuhui, et al.
Publicado: (2021) -
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020) -
Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
por: Jakabova, Anna, et al.
Publicado: (2021) -
Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer
por: Li, Yang, et al.
Publicado: (2018)